New Evidence Available
Updated Recommendation
A new evidence synthesis was published:2025, WHO updated recommendations on HIV clinical management: recommendations for a public health approach
View latest version (2025)Bibliographic Info
GuidelineConsolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach
Year of Publication2016
Issuing InstitutionWHO
Recommendation
Status
Retired
Recommended in favor
Strong
Certainty of evidence
Moderate
If tenofovir disoproxil fumarate (TDF) + lamivudine (3TC ) or emtricitabine (FTC) + efavirenz (EFV) is contraindicated or not available, one of the following alternative options is recommended: ° zidovudine (AZT) + 3TC + EFV ° AZT + 3TC + NVP ° TDF + 3TC (or FTC) + nevirapine (NVP)